The Influence of Anti-TNF Therapy on the Course of Chronic Hepatitis C Virus Infection in Patients with Inflammatory Bowel Disease
- 20 November 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Digestive Diseases and Sciences
- Vol. 58 (4), 1149-1156
- https://doi.org/10.1007/s10620-012-2457-0
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Review article: chronic viral infection in the anti‐tumour necrosis factor therapy era in inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2009
- Diagnosis, management, and treatment of hepatitis C: An updateJournal of Hepatology, 2008
- Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative ColitisInflammatory Bowel Diseases, 2008
- Hepatitis C Virus and Inflammatory Bowel DiseaseDigestive Diseases and Sciences, 2008
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisThe New England Journal of Medicine, 2005
- Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled studyJournal of Hepatology, 2005
- Diagnosis, management, and treatment of hepatitis CJournal of Hepatology, 2004
- Tumor necrosis factor ? gene expression and the response to interferon in chronic hepatitis CJournal of Hepatology, 1996
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisThe New England Journal of Medicine, 1987
- A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITYThe Lancet, 1980